10-K 1 healthient_inc.htm
U. S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 10-K /A
(MARK ONE)
x
ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended June 30, 2013

o
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
 
Commission File Number 333-59114

HEALTHIENT, INC.
(Name of small business issuer in its charter)

NEVADA
33-0730042
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)

15132 Park of Commerce Blvd., Jupiter, FL
33478
(Address of principal executive offices)
(Zip Code)

Issuer's telephone number (including area code): (561) 935-6449

Securities registered under Section 12(b) of the Exchange Act:

None

Securities registered pursuant to Section 12(g) of the Exchange Act:

None
(Title of Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes x No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (17 CFR 229.405) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statement incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   o
 
 
 
 
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer or a smaller reporting company. See definition of "large accelerated filer", "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated file o
Accelerated filer   o
Non-accelerated filer o
Smaller reporting company   x
(Do not check if a smaller reporting company)
 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). Yes  o No x |

The registrant's revenues for its most recent fiscal year were $161,954.

The aggregate market value of the registrant’s common stock held by non-affiliates based upon the closing sales price of the common stock on September 18, 2013 of $0.07 per share, as reported by the FINRA OTC BB, was approximately $1,124,674. Shares of common stock held by each of the current executive officers and directors and by each person who is known by the registrant to own 5% or more of the outstanding common stock have been excluded from this computation in that such persons may be deemed to be affiliates of the registrant. This determination of affiliate status is not a conclusive determination for other purposes.

The number of shares outstanding of the registrant's only class of common stock, $0.001 par value per share, was 41,460,678 as of September 18, 2013. The registrant has no outstanding non-voting common equity.

DOCUMENTS INCORPORATED BY REFERENCE

None
 
 
 
 
 
TABLE OF CONTENTS

  PART I
   
Item 1.
Description of Business
1
Item 1A.
Risk Factors
12
Item 1B.
Unresolved Staff Comments
12
Item 2.
Description of Property
13
Item 3.
Legal Proceedings
13
Item 4.
Mine Safety Disclosures
13
     
PART II
   
Item 5.
Market for Common Equity, Related Stockholder Matters and Small Business Issuer Purchases of Equity Securities
14
Item 6.
Selected Financial Data
16
Item 7.
Management's Discussion and Analysis or Plan of Operation
17
Item 7A.
Quantitative And Qualitative Disclosures About Market Risk
24
Item 8.
Financial Statements and Supplementary Data
24
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
36
Item 9A.
Controls and Procedures
37
Item 9B.
Other Information
38
     
PART III
   
Item 10.
Directors, Executive Officers, And Corporate Governance
38
Item 11.
Executive Compensation
40
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
42
Item 13.
Certain Relationships and Related Transactions, and Director Independence
43
Item 14.
Principal Accountant Fees and Services
44
Item 15.
Exhibits and Financial Statement Schedules
45
 
 
 
 
 
PART I
 
ITEM 1. DESCRIPTION OF BUSINESS

General

Healthient, Inc., and its wholly owned subsidiary, SnackHealthy, Inc., develops and markets delicious snacks and beverages that make healthy eating a fun experience for the entire family. The Company’s goal is to successfully position a “better for you” portfolio of products to American families as convenient, healthy solutions to support the lifestyles of health conscious consumers.   We commenced sales in the third quarter ended March 31, 2011. Our principal executive offices are located at 15132 Park of Commerce Blvd., Jupiter, FL 33478 and our phone number is (561) 935-6449.
 
The Company is considered to be in the Development Stage as defined in Statement of Financial Accounting Standards (SFAS) No. 7, “Accounting and Reporting by Development Stage Enterprises”. The Company has devoted substantially all of its efforts to the corporate formation. Activities during the Development Stage include developing the business plan and raising capital.

Organization

Our Company was organized under the laws of the state of California on November 5, 1996 as Renet Services, Inc.  The name was changed to Time Lending, California, Inc. on August 4, 1998 and we reincorporated in the state of Nevada in December, 2000 by merging with Time Lending California, Inc., a Nevada corporation. Time Lending California, Inc. subsequently changed its name to "Time Associates, Inc."  Effective as of October 5, 2010, Time Associates, Inc. entered into an Agreement and Plan of Reorganization dated as of September 23, 2010 (the "Reorganization Agreement") with Healthient, Inc. a Nevada corporation organized April 29, 2009 ("Healthient") and Healthient shareholders. In accordance with the terms and provisions of the Reorganization Agreement, the Company acquired Healthient in exchange for 43,618,356 newly issued "restricted" shares of common voting stock of the Company to the Healthient shareholders on a pro rata basis for the purpose of effecting a tax-free reorganization pursuant to sections 351, 354 and 368(a)(1)(B) of the Internal Revenue Code of 1986, as amended. As a condition of the closing of the share exchange transaction, a majority shareholder of the Company cancelled all of his 188,572 shares. In addition, as a condition of the closing of the transaction, the Company spun off its operating subsidiary Time Marketing, Inc. Pursuant to the terms of the Reorganization Agreement, each one (1) share of common stock of Healthient has been exchanged for three (3) shares of the Company's common stock. Following the Closing Date, there were 43,778,433 shares of the Registrant's common stock outstanding. Immediately prior to the Closing, there were 160,077 shares issued and outstanding (assuming the cancellation of the shares held by the majority shareholder at the closing).  The shareholders of Healthient owned 99.6% of the common stock outstanding of the Company after the issuance of the 43,618,356 shares. On November 15, 2010 Time Associates, Inc. changed its name to "Healthient, Inc."
   
The acquisition of Healthient by the Company on October 5, 2010 has been accounted for as a purchase and treated as a reverse acquisition and re-capitalization since the former owners of Healthient controlled 99.6% of the total shares of common stock of the Company outstanding immediately following the acquisition. In November 2010 Healthient, Inc. changed its name to "SnackHealthy, Inc."  SnackHealthy, Inc., a Nevada corporation is a wholly-owned subsidiary of the Company.
 
 
1
 
 
On July 19, 2010 the Company effected a seventy (70) for one (1) reverse stock split of its common stock. There were 23,398,040 shares of common stock outstanding before the reverse stock split and 348,649 after the stock split.

As of August 7, 2010, the Company sold two of its fifty-percent owned subsidiaries, Time Management, Inc. and Tenth Street, Inc. to those companies’ shareholders for a price of $10.00 each.

On this basis, the historical financial statements prior to October 5, 2010 have been restated to be those of the accounting acquirer Healthient (now SnackHealthy, Inc.). The historical stockholders' equity prior to the reverse acquisition has been retroactively restated (a re-capitalization) for the equivalent number of shares received in the acquisition after giving effect to any difference in par value of the issuer's and acquirer's stock. The original 160,078 shares of common stock outstanding prior to the exchange reorganization have been reflected as an addition in the stockholders' equity account of the Company on October 5, 2010.

Business Overview

We are in the business of manufacturing, distribution, marketing and sale of healthy and ‘better for you” snack food and beverage products. These products include freeze dried fruit, dehydrated fruit, low fat microwave popcorn, nut and fruit snacks, low sodium pretzels, fruit bars, energy drink mixes and protein shake mixes. Our products are packaged in various single-serve, multi-pack and family-size configurations.
 
  Product Overview
 
Our products are designed to help consumers achieve and maintain their healthy weight, improve their health and experience life-changing results. Our snacks and beverages appeal to the growing base of consumers seeking differentiated products and desiring a healthier lifestyle.
 
Our products may often be sold as part of a program, and therefore our portfolio is comprised of a series of related products designed to simplify weight management and nutrition for our consumers and maximize cross-selling opportunities. These programs target specific consumer market segments, such as women, men or children, as well as weight-management customers and individuals looking to enhance their overall well being.
 
Our portfolio includes; Smart Shake Chocolate and Vanilla, our sugar free Whey protein shakes fortified with fiber; CrispyFruit a light and crispy fruit with no added sugar; LoliBars the wholesome whole wheat fruit filled cookie bar; RealFruit chewy, delicious dried fruit with no added sugars; Lite Natural Microwave Popcorn Mini Bags; Multigrain Pretzel Nuggets; LoliCrunch a delicious fruit and nut crunch; and Zing! our healthy Energy Drink Mix.
 
 
2
 
 
Product Development
 
We are committed to providing consumers with delicious healthy snacks and beverage mixes to help them achieve and maintain their healthy weight. We believe this can be best accomplished in part by introducing new products and by upgrading, reformulating and repackaging existing product lines.
 
New product ideas are generated and narrowed down to high potential ideas that fill our business needs and conform to our overall strategy. We test the most promising ideas with brand partners and customers. This testing is followed by a feasibility assessment, which includes a review of product and package prototypes, product positioning and messaging, process design and analysis of manufacturing issues.
 
The next stage is the development phase in which we finalize the formula, process, manufacturing strategy, product positioning, pricing, labeling and other related matters. The fourth stage is the launch phase in which we prepare promotional and sales materials, complete the supply chain plan and complete other final preparations for launch. After the product is launched, we will closely track sales performance and the lessons learned so we can update and improve the product development process.
 
  Manufacturing
 
Our products are manufactured by third parties. We work closely with our vendors in an effort to achieve the highest quality standards and product availability. We continually strive to establish excellent relationships with our manufacturers and to obtain improvements in product quality and product delivery. Some of our key input materials such as whey proteins and packaging materials are subject to pricing fluctuations driven by commodities pricing. We are confident that we can offset potential cost increases of these materials with volume increases in our inventory purchases and, when necessary, by raising the prices of our products.
 
In order to coordinate and manage the manufacturing of our products, we will utilize a demand planning and forecasting process that is directly tied to our production planning and purchasing systems. Using a planning process allows us to balance our inventory levels while minimizing working capital and inventory obsolescence.
 
Intellectual Property
 
Trademarks that are important to our business will be protected by registration or other means in the United States and most other markets where the related products are sold.  We do not have any registered trademarks at this time.

 
3
 
 
Research and Development

We consider research and development of new products to be a significant part of our overall philosophy and we are committed to developing innovative, high-quality products that exceed consumer expectations. In addition to developing new products, we may from time to time reformulate and improve existing products based on advances in ingredients and technology.   We have not spent any significant amount of funds on research and development in fiscal 2013.

Distribution
 
Our products are sold under trade names owned by the Company. Shipping and processing standards for orders placed are either same day or the following business day. Products are distributed in the United States market from our warehouse and distribution center in Florida.
 
We plan to distribute snack food products throughout the United States using a direct-store-delivery (“DSD”) network of distribution routes, most of which will serviced by IBOs and others that may be company-owned.

Customers

We sell our products to grocery/mass merchandisers, club stores, discount stores, convenience stores, food service establishments and various other retailers including drug stores, schools, military and government facilities and “up and down the street” outlets such as recreational facilities, offices and other independent retailers. Consumers can also purchase our products directly from the Company on snackhealthy.com.
 
Competition and Industry

Our products are sold in highly competitive markets. Generally, we compete with manufacturers, many of whom have greater revenues and resources than we do. The principal methods of competition are price, service, product quality, product offerings and distribution. The methods of competition and our competitive position vary according to the geographic location, the particular products and the activities of our competitors.

Environmental Matters

Our operations in the United States are subject to various federal, state and local laws and regulations with respect to environmental matters. However, the Company was not a party to any material proceedings arising under these laws or regulations for the periods covered by this Form 10-K. We believe the Company is in compliance with all material environmental regulations affecting our facility and operations and that continued compliance will not have a material impact on our capital expenditures, earnings or competitive position.
 
 
4
 
   
Available Information
 
Our Internet website addresses are www.healthient.com and www.snackhealthy.com. We make available free of charge on our website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K as soon as reasonably practical after we file such material with, or furnish it to, the Securities and Exchange Commission, or SEC. This information is also available in print to any shareholder who requests it, with any such requests addressed to Investor Relations, 15132 Park of Commerce Boulevard, Second Floor, Jupiter, Florida 33478.  Certain of these documents may also be obtained by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet website that contains reports, and other information regarding issuers that file electronically with the SEC at www.sec.gov . 

Item 1A.   Risk Factors
 
In addition to the other information in this Form 10-K, the following risk factors should be considered carefully in evaluating our business. Our business, financial condition or results of operations may be adversely affected by any of these risks. Additional risks and uncertainties, including risks that we do not presently know of or currently deem insignificant, may also impair our business, financial condition or results of operations.

Our performance may be impacted by general economic conditions and an economic downturn.
Recessionary pressures from an overall decline in U.S. economic activity could adversely impact our business and financial results. Economic uncertainty may reduce consumer spending in our sales channels and create a shift in consumer preference toward private label products. Shifts in consumer spending could result in increased pressure from competitors or customers to reduce the prices of some of our products and/or limit our ability to increase or maintain prices, which could lower our revenues and profitability. Instability in the financial markets may impact our ability or increase the cost to enter into credit agreements in the future. Additionally, it may weaken the ability of our customers, suppliers, IBOs, distributors, banks, insurance companies and other business partners to perform in the normal course of business, which could expose us to losses or disrupt the supply of inputs we rely upon to conduct our business. If one or more of our key business partners fail to perform as expected or contracted for any reason, our business could be negatively impacted.

Volatility in the price or availability of the inputs we depend on, including raw materials, packaging, energy and labor, could adversely impact our financial results. Our financial results could be adversely impacted by changes in the cost or availability of raw materials and packaging.
Continued growth would require us to hire, retain and develop a highly skilled workforce and talented management team. Any unplanned turnover or our failure to develop an adequate succession plan for current positions could erode our competitiveness. In addition, our financial results could be adversely affected by increased costs due to increased competition for employees, higher employee turnover or increased employee benefit costs.

We operate in a highly competitive food industry.
Price competition and industry consolidation could adversely impact our financial results. The sales of most of our products are subject to significant competition primarily through discounting and other price cutting techniques by competitors, many of whom are significantly larger and have greater resources than we do. In addition, there is a continuing consolidation in the snack food industry, which could increase competition. Significant competition increases the possibility that we could lose one or more major customers, lose existing product authorizations at customer locations, lose market share and/or shelf space, increase expenditures or reduce selling prices, which could have an adverse impact on our business or financial results.
Sales price increases initiated by us may negatively impact our financial results. Future price increases, such as those to offset increased ingredient costs, may reduce our overall sales volume, which could reduce revenues and operating profit. Additionally, if market prices for certain ingredients decline significantly below our contracted prices, customer pressure to reduce prices could lower revenues and operating profit.
 
 
5
 

Changes in our top customer relationships could impact our revenues and profitability.
We may be exposed to risks resulting from large retailers that could account for a significant portion of our revenue. The loss of one or more large retailers could adversely affect our financial results. These customers typically make purchase decisions based on a combination of price, product quality, product offerings, consumer demand, distribution capabilities and customer service and generally do not enter into long-term contracts. In addition, these significant retailers may re-evaluate or refine their business practices related to inventories, product displays, logistics or other aspects of the customer-supplier relationship. Our results of operations could be adversely affected if revenue from one or more of these customers is significantly reduced or if the cost of complying with customers’ demands is significant. If receivables from one or more of these customers become uncollectible, our financial results may be adversely impacted.

The loss of key personnel could have an adverse effect on our financial results and growth prospects.
There are risks associated with our ability to retain key employees. If certain key employees terminate their employment, it could negatively impact sales, marketing or development activities. Further, management’s attention might be diverted from operations to recruiting suitable replacements and our financial condition, results of operations and growth prospects could be adversely affected. In addition, we may not be able to locate suitable replacements for key employees or offer employment to potential replacements on acceptable terms.

Efforts to execute and accomplish our strategic initiatives could adversely affect our financial results.
If we are unsuccessful due to our execution, unplanned events, ability to manage change or unfavorable market conditions, our financial performance could be adversely affected. If we pursue strategic acquisitions, divestitures, or joint ventures, we may incur significant costs and may not be able to consummate the transactions or obtain financing.

Concerns with the safety and quality of certain food products or ingredients could cause consumers to avoid our products.
We could be adversely affected if consumers in our principal markets lose confidence in the safety and quality of certain products or ingredients. Negative publicity about these concerns, whether or not valid, may discourage consumers from buying our products or cause disruptions in production or distribution of our products and negatively impact our business and financial results.

If our products become adulterated, misbranded or mislabeled, we might need to recall those items and we may experience product liability claims if consumers are injured or become sick. Product recalls or safety concerns could adversely impact our market share and financial results. We may be required to recall certain of our products should they be mislabeled, contaminated or damaged. We also may become involved in lawsuits and legal proceedings if it is alleged that the consumption of any of our products causes injury or illness. A product recall or an adverse result in any such litigation could have an adverse effect on our operating and financial results. We may also lose customer confidence for our entire brand portfolio.

Disruption of our supply chain or information technology systems could have an adverse impact on our business and financial results.
Our ability to manufacture, distribute and sell products is critical to our success. Damage or disruption to our manufacturing or distribution capabilities or the supply and delivery of key inputs, such as raw materials, finished goods, packaging, labor and energy, could impair our ability to conduct our business. Examples include, but are not limited to, weather, natural disasters, fires, terrorism, pandemics and strikes. Certain warehouses and manufacturing facilities may be located in areas prone to tornadoes, hurricanes and floods. Any business disruption due to natural disasters or catastrophic events in these areas could adversely impact our business and financial results if not adequately mitigated. We also rely on a certain supplier for the manufacturing of one of our core branded products. Although we have secured back-up suppliers in the case of emergency, any damage or disruption to this supplier's manufacturing or distribution capabilities could impair our ability to sell this product.
Also, we increasingly rely on information technology systems to conduct our business. These systems can enhance efficiency and business processes but also present risks of unauthorized access to our networks or data centers. If unauthorized parties gain access to our systems, they could obtain and exploit confidential business, customer, or employee information and harm our competitive position. Further, these information systems may experience damage, failures, interruptions, errors, inefficiencies, attacks or suffer from fires or natural disasters, any of which could have an adverse effect on our business and financial results if not adequately mitigated by our security measures and disaster recovery plans.
 
 
6
 

Improper use or misuse of social media may have an adverse effect on our business and financial results.
Consumers are moving away from traditional means of electronic mail towards new forms of electronic communication, including social media. We support new ways of sharing data and communicating with customers using methods such as social networking. However, misuse of social networking by individuals, customers, competitors, or employees may result in unfavorable media attention which could negatively affect our business. Further, our competitors are increasingly using social media networks to market and advertise products. If we are unable to compete in this environment it could adversely affect our financial results.

Demand for our products may be adversely affected by changes in consumer preferences and tastes or if we are unable to innovate or market our products effectively. We are a consumer products company operating in highly competitive markets and rely on continued demand for our products. To generate revenues and profits, we must sell products that appeal to our customers and consumers. Any significant changes in consumer preferences or any inability on our part to anticipate or react to such changes could result in reduced demand for our products and erosion of our competitive and financial position. Our success depends on the ability to respond to consumer trends, including concerns of consumers regarding health and wellness, obesity, product attributes and ingredients. In addition, changes in product category consumption or consumer demographics could result in reduced demand for our products. Consumer preferences may shift due to a variety of factors, including the aging of the general population, changes in social trends, changes in travel, vacation or leisure activity patterns, or negative publicity resulting from regulatory action or litigation against companies in the snack food industry. Any of these changes may reduce consumers’ willingness to purchase our products and negatively impact our financial results.

Our continued success also is dependent on product innovation, including maintaining a robust pipeline of new products, and the effectiveness of advertising campaigns, marketing programs and product packaging. Although we devote significant resources to meet this goal, there can be no assurance as to the continued ability to develop and launch successful new products or variants of existing products, or to effectively execute advertising campaigns and marketing programs. In addition, both the launch and ongoing success of new products and advertising campaigns are inherently uncertain, especially as to their appeal to consumers. Further, failure to successfully launch new products could decrease demand for existing products by negatively affecting consumer perception of existing brands, as well as result in inventory write-offs, trademark impairments and other costs, all of which could negatively impact our financial results.

Our distribution network relies on a significant number of IBOs, and such reliance could affect our ability to efficiently and profitably distribute and market products, maintain existing markets and expand business into other geographic markets. Our business relies on IBOs for the sale and distribution of our products.  Our ability to recruit and maintain a network of IBOs and distributors depends on a number of factors, many of which are outside of our control. Some of these factors include: (i) the level of demand for the brands and products which are available in a particular distribution area; (ii) the ability to price products at levels competitive with those offered by other competing producers; and (iii) the ability to deliver products in the quantity and at the time ordered by IBOs and retailers. There can be no assurance that we will be able to mitigate the risks related to all or any of these factors in any of the current or prospective geographic areas of distribution. To the extent that any of these factors have an adverse effect on the relationships with IBOs in a particular geographic area and, thus, limit our ability to maintain and expand the sales market, revenues and financial results may be adversely impacted.

Identifying new IBOs or distributors can be time-consuming and any resulting delay may be disruptive and costly to the business. There also is no assurance that we will be able to maintain distribution relationships or establish and maintain successful relationships with IBOs in new geographic distribution areas. There is the possibility that we will have to incur significant expenses to attract and maintain IBOs in one or more geographic distribution areas in order to profitably expand geographic markets. The occurrence of any of these factors could result in a significant decrease in sales volume of our branded products and the products which we distribute for others and harm our business and financial results.
 
 
7
 

Continued success depends on the protection of our trademarks and other proprietary intellectual property rights.
We will maintain trademarks and other intellectual property rights, which are important to our success and competitive position, and the loss of or our inability to enforce trademark and other proprietary intellectual property rights could harm our business. We will devote substantial resources to the establishment and protection of our trademarks and other proprietary intellectual property rights on a worldwide basis. Efforts to establish and protect trademarks and other proprietary intellectual property rights may not be adequate to prevent imitation of products by others or to prevent others from seeking to block sales of our products. In addition, the laws and enforcement mechanisms of some foreign countries may not allow for the protection of proprietary rights to the same extent as in the United States and other countries.

Impairment in the carrying value of goodwill or other intangible assets could have an adverse impact on our financial results.
The net carrying value of goodwill represents the fair value of acquired businesses in excess of identifiable assets and liabilities, and the net carrying value of other intangibles represents the fair value of trademarks, customer relationships and other acquired intangibles. Pursuant to generally accepted accounting principles in the United States, we are required to perform impairment tests on our goodwill and indefinite-lived intangible assets annually or at any time when events occur which could impact the value of our reporting units or our indefinite-lived intangibles. These values depend on a variety of factors, including the success of our business, market conditions, earnings growth and expected cash flows. Impairments to goodwill and other intangible assets may be caused by factors outside our control, such as increasing competitive pricing pressures, changes in discount rates based on changes in cost of capital or lower than expected sales and profit growth rates. Significant and unanticipated changes could require a non-cash charge for impairment in a future period which may significantly affect our financial results in the period of such charge.

New regulations or legislation could adversely affect our business and financial results.
Food production and marketing are highly regulated by a variety of federal, state and other governmental agencies. New or increased government regulation of the food industry, including but not limited to areas related to food safety, chemical composition, production processes, traceability, product quality, packaging, labeling, school lunch guidelines, promotions, marketing and advertising (particularly such communications that are directed toward children), product recalls, records, storage and distribution could adversely impact our results of operations by increasing production costs or restricting our methods of operation and distribution. These regulations may address food industry or society factors, such as obesity, nutritional and environmental concerns and diet trends.

A significant portion of our outstanding shares of common stock is controlled by a few individuals, and their interests may conflict with those of other stockholders. The founders, William M. Alverson and his wife, Katherine T. Alverson, beneficially owned a majority of the outstanding common stock of the Company. Mr. and Mrs. Alverson serve as directors of the Company, with Mrs. Alverson serving as President and Mr. Alverson serving as the Chairman of the Board. As a result, the Alverson may be able to exercise significant influence over the Company and certain matters requiring approval of its stockholders, including the approval of significant corporate transactions, such as a merger or other sale of the Company or its assets. This could limit the ability of other stockholders of the Company to influence corporate matters and may have the effect of delaying or preventing a third party from acquiring control of the Company. In addition, the Alversons may have actual or potential interests that diverge from the interests of the other stockholders of the Company. Sales by the Alversons of their shares into the public market, or the perception that such sales could occur, could cause the market price of our common stock to decline.
 
Item 1B.   Unresolved Staff Comments

None.
 
 
8
 
 
ITEM 2. DESCRIPTION OF PROPERTIES
 
Our facility in Jupiter, Florida is 4,500 feet of office workspace for computers, printers and office equipment with an adjacent area for packaging, shipping and storage.  The current facility lease runs from July 1, 2011 through June 30, 2016 with an option for a five year extension. Our lease payments are $4,226 per month including operating expense and tax during the first year and subject to a three percent increase after each of the following four years.  We maintain our executive and administrative offices in this facility.  Our rental payments in fiscal 2013 were $49,542. Our rental payments in fiscal 2012 were $75,917.  Future minimum payments under the office lease are approximately as follows:  year ended June, 2014, $54,000; 2015, $55,000; 2016, $56,000; for a total of $161,000.
 
We believe that our existing facilities are adequate to meet our current needs and that suitable additional or alternative space will be available after 2016. We have no assurance that future terms would be as favorable as our current terms.
 
The Company has not invested in any real property at this time, nor does the Company intend to do so. The Company has no formal policy with respect to investments in real estate or investments with persons primarily engaged in real estate activities.
 
ITEM 3. LEGAL PROCEEDINGS

In 2011 Siesta Flow LLC filed a legal action against the Company in the Twelfth Circuit Court of Sarasota County, Florida, alleging breach of contract and seeking damages in the amount of approximately $95,000 plus costs. In April, 2012, the court has issued final summary judgment against the Company in the total amount of $95,000, which amount was subsequently settled in the amount of $75,000 and satisfied by the Company.

In June of 2013, a former officer of the Company filed a lawsuit against the Company and its Preseident and directors alleging several counts, including a breach of contract and fiduciary duty, and seeking damages in the amount of $122,300 and other unspecified damages.  The Company considers the lawsuit without any merit and will defend it vigorously.  On September 18, 2013, the plaintiff filed a motion to compel early mediation.
 
ITEM 4.  MINE SAFETY DISCLOSURES

Not applicable.
 
 
9
 
 
PART II
 
ITEM 5. MARKET FOR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND SMALL BUSINESS ISSUER PURCHASES OF EQUITY SECURITIES
 
PUBLIC MARKET

Our common stock trades on FINRA's over-the-counter market, the Bulletin Board under the symbol "SNAX ". Our common stock has been trading under that symbol since the reverse merger with Time Associates, Inc. on October 5, 2010.  As of June 30, 2013 there were 183 holders of our common stock and the closing price of our common stock as of was $0.07 per share.  As of August 11, 2010, we effected a reverse stock split of 1-to-70 of our common stock.  As of October 1, 2012, we effected a reverse stock split of 1-to-50 of our common stock.  All shares and per share amounts in the accompanying financial statements of the Company have been retroactively adjusted to give the effects of said reverse stock splits.
 
   
SHARE BID PRICE
 
Fiscal 2012
 
High
   
Low
 
Fourth quarter (6/30/12)
 
$
0.15
   
$
0.03
 
Third quarter (3/31/12)
 
$
0.20
   
$
0.07
 
Second quarter (12/31/11)
 
$
0.38
   
$
0.07
 
First quarter (9/30/11)
 
$
0.34
   
$
0.07
 
Fiscal 2013
 
High
   
Low
 
Fourth quarter (6/30/13)
 
$
0.08
   
$
0.05
 
Third quarter (3/31/13)
 
$
0.32
   
$
0.32
 
Second quarter (12/31/12)
 
$
0.42
   
$
0.42
 
First quarter (9/30/12)
 
 $
1.00
   
 $
1.00
 
                 

DIVIDENDS

The Company does not expect to pay any dividends at this time. The payment of dividends, if any, will be contingent upon the Company's revenues and earnings, if any, capital requirements, and general financial condition. The payment of any dividends will be within the discretion of the Company's Board of Directors and may be subject to restrictions under the terms of any debt or other financing arrangements that the Company may enter into in the future. The Company presently intends to retain all earnings, if any, for use in the Company's business operations and accordingly, the Board does not anticipate declaring any dividends in the foreseeable future.

RECENT SALES OF UNREGISTERED SECURITIES

Effective as of October 5, 2010, Time Associates, Inc., a Nevada corporation (the “Registrant”) entered into an agreement and plan of reorganization dated as of September 23, 2010 (the "Reorganization Agreement") with Healthient, Inc., a Nevada corporation ("Healthient") and Healthient shareholders. In accordance with the terms and provisions of the Reorganization Agreement, the Registrant acquired Healthient in exchange for 43,618,356 newly issued "restricted" shares of common voting stock of the Registrant to the Healthient shareholders on a pro rata basis for the purpose of effecting a tax-free reorganization pursuant to sections 351, 354 and 368(a)(1)(B) of the Internal Revenue Code of 1986, as amended. Pursuant to the terms of the Reorganization Agreement, each one (1) share of common stock of Healthient has been exchanged for three (3) shares of the Registrant's common stock. The shares of common stock issued to the Healthient shareholders in connection with the Reorganization (43,618,356) were not registered under the Securities Act, in reliance upon an exemption from registration provided by Section 4(2) and/or 4(6) under the Securities Act and Regulation D promulgated thereunder.
 
 
10
 
 
On October 10, 2010, the Company issued a total of 384,500 shares of common stock through its private placement of shares of common stock at a purchase price of $0.22 per share for a total amount of $86,128, to an “accredited investor”, as that term is defined in Regulation D of the Securities Act of 1933.

On October 13, 2010, the Company issued a total of 375,000 shares of common stock through its private placement of shares of common stock at a purchase price of $0.27 per share for a total amount of $100,000, to an “accredited investor”, as that term is defined in Regulation D of the Securities Act of 1933.
   
On November 2, 2010, the Company issued a total of 30,000 shares of common stock through its private placement of shares of common stock at a purchase price of $0.22 per share for a total amount of $6,720, to an “accredited investor”, as that term is defined in Regulation D of the Securities Act of 1933.
   
On November 29, 2010, the Company issued a total of 190,307 shares of common stock through its private placement of shares of common stock at a purchase price of $0.25 per share for a total amount of $47,130, to an “accredited investor”, as that term is defined in Regulation D of the Securities Act of 1933.
 
On December 7, 2010, the Company issued a total of 82,630 shares of common stock through its private placement of shares of common stock at a purchase price of $0.17 per share for a total amount of $13,768, to an “accredited investor”, as that term is defined in Regulation D of the Securities Act of 1933.
 
On December 14, 2010, the Company issued a total of 373,848 shares of common stock through its private placement of shares of common stock at a purchase price of $0.20 per share for a total amount of $73,539, to an “accredited investor”, as that term is defined in Regulation D of the Securities Act of 1933.
 
On January 20, 2011 the Company issued a total of 60,000 shares of common stock through its private placement of shares of common stock at a purchase price of $0.50 per share for a total amount of $30,000, to an “accredited investor”, as that term is defined in Regulation D of the Securities Act of 1933.
 
On April 11, 2011 the Company issued a total of 20,000 shares of common stock through its private placement of shares of common stock at a purchase price of $0.50 per share for a total amount of $10,000, to an “accredited investor”, as that term is defined in Regulation D of the Securities Act of 1933.
 
On June 7, 2011 the Company issued a total of 100,000 shares of common stock through its private placement of shares of common stock at a purchase price of $0.20 per share for a total amount of $20,000, to an “accredited investor”, as that term is defined in Regulation D of the Securities Act of 1933.
 
 In the quarter ended September 30, 2011, the Company issued 3,339,290 shares of common stock through its private placement of shares of common stock for a total amount of $347,679, to an "accredited investor", as that term is defined in Regulation D of the Securities Act of 1933.  The proceeds of the sale were used for working capital.  The Company also issued a total of 1,150,000 shares of common stock for services valued at $0.15 per share, for a total amount of $172,500; a total of 1,500,000 shares of common stock for services valued at $0.21 per share, for a total amount of $315,000; and a total of 1,000,000 shares of common stock for services valued at $0.09 per share.  The shares of the Company's common stock were issued and sold in reliance upon the exemption provided by Section 4(2) and Regulation D of the Securities Act of 1933. 
 
During the quarter ended December 31, 2011, the Company issued 507,800 shares of common stock through its private placement of shares of common stock for a total amount of $91,560, to an "accredited investor", as that term is defined in Regulation D of the Securities Act of 1933. The Company also issued a total of 12,000,000 shares of common stock for services valued at $0.08 per share for a total of $960,000; and a total of 115,000 shares of common stock valued at $0.08 per share for a total of $9,200.  The proceeds of the sale were used for the working capital.  The shares of the Company's common stock were issued and sold in reliance upon the exemption provided by Section 4(2) and Regulation D of the Securities Act of 1933. 

 
11
 
 
During the quarter ended March 31, 2012, the Company issued 240,071 shares of common stock for services valued at $0.14 per share for a total of $33,610 and 485,000 shares of common stock for services valued at $0.13 per share for a total of $63,050.  The shares of the Company's common stock were issued and sold in reliance upon the exemption provided by Section 4(2) and Regulation D of the Securities Act of 1933. 

During the quarter ended June 30, 2012, the Company issued 4,000,000 shares of common stock for services valued at $0.12 per share for a total of $480,000; a total of 60,000 shares of common stock for services valued at $0.07 per share for a total of $4,200; and a total of 36,653,568 shares for a debt conversion valued at $0.05 per share for a total of $1,649,410.  The shares of the Company's common stock were issued and sold in reliance upon the exemption provided by Section 4(2) and Regulation D of the Securities Act of 1933. 

On October 1, 2012 the Company effected a 50 to 1 reverse split of its common stock.

 In fiscal year ended June 30, 2013, the Company issued certain number of shares as set forth below pursuant to the order of the Circuit Court of the Twelfth Judicial Circuit, Florida, in the settlement of the lawsuit against the Company by Siesta Flow, LLC.,  in the amount of $95,195.99 in exchange for the issuance of a total of 19,100,000 shares of common stock (the "Settlement Shares") to a purchaser of the judgement claim, subject to certain limitations.  In the quarter ended December 31, 2012, the Company issued 350,000 shares of common stock; in the quarter ended March 31, 2013, the Company issued 13,450,000 shares of common stock, and in the quarter ended June 30, 2013, the Company issued 584,000 shares of common stock of the Settlement Shares (see also Note 7 to the Company's Financial Statements).  The shares of the Company's common stock were issued in reliance upon the exemption provided by Section 3(a)(10) of the Securities Act of 1933.

ITEM 6: SELECTED FINANCIAL DATA

As a “smaller reporting company”, we are not required to provide the information required by this Item .
 
 
12
 
 
ITEM 7.  MANAGEMENT'S DISCUSSION OF FINANCIAL CONDITION AND RESULTS OF OPERATION
 
Forward-Looking Statements

This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include the words “may,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” and any other similar words.  Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward- looking statements include, among others, the following:
     
●
product liability claims;
   
●
our relationship with, and our ability to influence the actions of, our brand partners;
   
●
adverse publicity associated with our products or network marketing organization;
   
●
improper action by our employees or international brand partners in violation of applicable law;
   
●
changing consumer preferences and demands;
   
●
loss or departure of any member of our senior management team which could negatively impact our brand partner relations and operating results;
   
●
the competitive nature of our business;
   
●
regulatory matters governing our products, including potential governmental or regulatory actions concerning the safety or efficacy of our products, and network marketing program including the direct selling market in which we operate;
   
●
third party legal challenges to our network marketing program;
   
●
risks associated with operating internationally and the effect of economic factors, including foreign exchange, inflation, pricing and currency devaluation risks;
   
●
our dependence on increased penetration of existing markets;
   
●
contractual limitations on our ability to expand our business;
   
●
our reliance on our information technology infrastructure and outside manufacturers;
 
 
13
 
 
●
the sufficiency of trademarks and other intellectual property rights;
   
●
the sufficiency of trademarks and other intellectual property rights;
   
●
product concentration;
   
●
our reliance on our management team;
   
●
uncertainties relating to the application of transfer pricing, duties, value added taxes, and other tax regulations, and changes thereto;
   
●
changes in tax laws, treaties or regulations, or their interpretation; • taxation relating to our brand partners;
   
●
any collateral impact resulting from the ongoing worldwide financial “crisis,” including the availability of liquidity to us, our customers and our suppliers or the willingness of our customers to purchase products in a recessionary economic environment; and
   
●
whether we will purchase any of our shares in the open markets or otherwise.
      
Additional factors that could cause actual results to differ materially from our forward-looking statements are set forth in this Annual Report on Form 10-K, including under the heading “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in our Consolidated Financial Statements and the related Notes.
 
Forward-looking statements in this Annual Report on Form 10-K speak only as of the date hereof, and forward- looking statements in documents attached that are incorporated by reference speak only as of the date of those documents. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
 
Overview
 
As a development stage, snack food company, we have been primarily engaged in developing our infrastructure and a product portfolio of snacks and beverage mixes designed to help people achieve and maintain their healthy weight.  We commenced sales of two products from our product lines in the third quarter of fiscal year 2011 and had net revenue of $314,980 for the fiscal year ended June 30, 2012.

During 2013, we began to implement our strategic plan, which provides for future growth of our existing core brands through a new expanded distribution method, innovation and advertising. Our primary focus was on decreasing general and administrative costs associated with network marketing and improving sales and profit margins through pricing strategies and enhanced packaging and product configuration. To accomplish this we began the process of winding down the network marketing sales in order to better position the Company to serve retailers and ultimately, the end consumer. We completed this project in the last quarter of fiscal 2013 and the Company is now prepared to focus on mass retail distribution.
 
 
14
 
 
Our products are grouped in two principal categories: weight management and energy, sports & fitness, along with premium marketing websites and promotional items. Our products are often sold in packages that are comprised of a variety of related products designed to simplify healthy snacking and weight management for consumers and to maximize cross-selling opportunities for us.
 
Industry wide factors that affect us include the increasing prevalence of obesity in adults and children, which are driving the demand for healthier snacking alternatives.
 
Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary SnackHealthy, Inc. All significant inter–company transactions and balances have been eliminated in consolidation.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents.

Financial Instruments

The carrying value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and due to related parties, as reported in the accompanying balance sheets, approximates fair value.
 
Long-Lived Assets

In accordance with ASC 350, the Company regularly reviews the carrying value of intangible and other long-lived assets for the existence of facts or circumstances, both internally and externally, that may suggest impairment. If impairment testing indicates a lack of recoverability, an impairment loss is recognized by the Company if the carrying amount of a long-lived asset exceeds its fair value.

Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

Revenue Recognition

Revenue is recognized when products are shipped, which is when title and risk of loss pass to brand partners and preferred customers who are the Company’s customers. The Company requires credit card payment at the point of sale. The Company has determined that no allowance for doubtful accounts is necessary. Amounts received prior to shipment and title passage to brand partners are recorded as deferred revenue. The compensation plan for the Company’s brand partners generally does not provide rebates or selling discounts to brand partners who purchase its products and services. The Company classifies selling discounts and rebates, if any, as a reduction of revenue.

Inventory

Inventory comprises packaged healthy snacks ready for final sale, and is stated at the lower of cost or market value. Cost is determined by the first-in, first out method.
 
 
15
 
 
Property and Equipment

Property and equipment are stated at cost and depreciated on the straight line method over the estimated life of the asset, which is 3-7 years.

Websites Development Cost and License to Produce Drink

The Company has adopted the provisions of FASB Accounting Standards Codification No. 350 Intangible-Goodwill and Other. Costs incurred in the planning state of a websites are expensed, while costs incurred in the development stage are capitalized and amortized over the estimated three year life of the asset. The drink license is also being amortized over three years.

Income Taxes

The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”) Income Taxes.  Under ASC 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
 
Going Concern

The financial statements have been prepared assuming that the Company will continue as a going concern. The Company had a net loss of $3,175,829 during the year ended June 30, 2013. Cash used in operations for the year approximated $157,000. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital and implement its business plan.

Management believes that the actions presently being taken and the success of future operations will be sufficient to enable the Company to continue as a going concern.

However, there can be no assurance that the raising of equity will be successful. Failure to achieve the needed equity funding could have a material adverse effect on the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
 
Stock-Based Compensation
 
In December 2004, the FASB issued FASB Accounting Standards Codification No. 718, Compensation – Stock Compensation .  Under FASB Accounting Standards Codification No. 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans.  As such, compensation cost is measured on the date of grant at their fair value.  Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.  The Company applies this statement prospectively.

 
16
 
 
Equity instruments (“instruments”) issued to other than employees are recorded on the basis of the fair value of the instruments, as required by FASB Accounting Standards Codification No. 718.  FASB Accounting Standards Codification No. 505, Equity Based Payments to Non-Employees defines the measurement date and recognition period for such instruments.  In general, the measurement date is when either a (a) performance commitment, as defined, is reached or (b) the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification.

Basic and Diluted Net Loss per Common Share
 
Net Loss per Common Share is computed pursuant to FASB Accounting Standards Codification No. 260, Earnings per Share .  Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed in the same way as for Basic net loss.

There are no warrants outstanding as of June 30, 2013.

Recent Accounting Pronouncements

There have been no recent accounting pronouncements of changes in accounting pronouncements that impacted the year ended June 30, 2013 and June 30, 2012, or which are expected to impact future periods, that were not already adopted and disclosed in prior periods.
 
Presentation
 
“Net sales,” reflect distribution allowances and handling and shipping income, represent what we collect and recognize as net revenues in our financial statements.
 
Our “gross profit” consists of net sales less “cost of sales,” which represents the prices we pay to our raw material suppliers and manufacturers of our products as well as costs related to product shipments to our warehouse and distribution center, duties and tariffs, expenses relating to shipment of products to brand partners and importers and similar expenses.
 
“Selling fees” are our most significant expense and consist of:
     
●
commissions, overrides and production bonuses which total approximately 20.03% of our net revenue.
   
●
other discretionary incentive cash bonuses.
   
  Our “operating margins” consist of net sales, less cost of sales and selling fees.
 
“General and administrative expenses” represent our operating expenses, components of which include labor and benefits, sales events, professional fees, travel and entertainment, marketing, occupancy costs, communication costs, bank fees, depreciation and amortization and other miscellaneous operating expenses.
 
 
17
 
 
Results of Operations
 
Our results of operations for the periods below are not necessarily indicative of results of operations for future periods, which depend upon numerous factors, including our ability to recruit new brand partners, retain existing brand partners, open new markets, further penetrate existing markets, introduce new products and programs that will help our brand partners increase their retail efforts and develop niche markets.
 
Net Sales
 
Net sales are directly associated with the efforts of our brand partner force, retailing of our products, the quality and completeness of our product offerings that we offer to consumers and retail stores.
 
Management’s role is to provide brand partners with a competitive and relevant product line, encourage strong teamwork and leadership among brand partners and offer leading edge business tools to make doing business with SnackHealthy simple and fun.
 
We believe that the correct business foundation, coupled with promotional initiatives, is required for the retention of retail customers and the in store retailing of our products. This correct business foundation includes strong management, a broad product line that appeals to consumer needs, a favorable regulatory environment, and a scalable and stable technology platform.
 
We anticipate that our strategy will continue to include creating and maintaining growth within existing markets, while expanding into new markets.
 
 
18
 
 
RESULTS OF OPERATIONS

Our results of operations for the periods below are not necessarily indicative of results of operations for future periods, which depend on numerous factors, including our ability to open new markets, further penetrate existing markets, introduce new products and programs that will help increase our retail efforts and develop niche markets.

Revenue

As anticipated, total revenue decreased compared to 2012 primarily due to winding down the network marketing distribution in the last half of the year. Revenues for the year ended June 30, 2013 were $161,954 as compared to $314,980 for the year ended June 30, 2012.  

Cost of Revenues

Costs of revenues were $105,672 largely due to a write down in inventory.

Gross Profit

Gross profit for fiscal year ending 2013 was $56,282.

Selling Expenses

Selling expenses were $19,952.
 
General and Administrative Expenses
 
   
GENERAL AND
ADMINSTRATIVE
 
   
6/30/25013
   
6/30/2012
 
Salaries and w ages
  $ 46,883     $ 792,738  
Independent contractors
    149,987       4,479,526  
Professional fees
    356,164       576,718  
Technology
    55,205       175,538  
Travel and entertainment
    12,181       86,281  
Office expenses
    21,455       59,435  
Utilities
    8,240       16,507  
Rent
    54,384       75,917  
Amoritization
    62,832       59,118  
Depreciation
    3,250       3,388  
Other
    104,054       11,095  
                 
    $ 874,635     $ 6,336,261  

General and administrative expenses consist primarily of compensation and benefits to our general management, finance and administrative staff, professional advisor fees, audit fees and other expenses incurred in connection with general operations.  Our general and administrative expenses for the year ended June 30, 2013 were $874,635, which represented a decrease of $5,461,626 compared to the same period in 2012.  The decrease was primary due to an issuance of common stock for independent contractors of $4,479,526 during the year ended June 30, 2012 as compared to the $149,987 of expense for independent contractors in 2013. Salaries and wages also decreased year over year because $720,000 of shares were issued for wages for the year ended June 30, 2012.

Travel and entertainment decreased from $86,281 to $12,181 as a direct result of winding down the network marketing distribution system.
 
 
19
 
 
Settlement Loss 

During the year ended June 30, 2012 the Company settled a lawsuit by agreeing to issue 19,100,000 shares of common stock. During the year the Company issued 9,124,000 shares at the market price valued at $7,562,500 (see Financial Statements).
 
Provision for Income Taxes

None.

Net Loss

Net loss for the year ended June 30, 2013 was $6,637,805 (including settlement expenses of $5,799,500) as compared to $7,998,164 (included settlement expenses of $1,719,000) for the same period in 2012. The decrease was due primarily to the issuance of stock for independent contractor and wage expenses in the year ended June 30, 2012.
 
Liquidity and Capital Resources

Generally, our principal uses of cash includes operating expenses, particularly selling expenses, and working capital (principally inventory purchases), as well as capital expenditures and the development of operations in new markets.  The capital expenditures to date have been primarily related to the following:
   
 
●
purchases of computer systems and software and development costs;
 
●
the build-out and upgrade of leasehold improvements in our new corporate headquarters;
 
●
the purchase of office furniture, phone systems and equipment;
 
●
product inventory.

The Company anticipates it will need to raise additional funds during the next twelve months in order to sustain the growth of our business
 
 
20
 

As the Company completes it second year of operations it will require funds to build and replenish inventory and increase sales.  The Company plans to continue to raise funds through the sales of common stock and to obtain credit from vendors for the purchase of inventory.   The Company had a negative working capital ratio as follows:

Total current assets
 
$
64,005
 
Total current liabilities
   
670,883
 
         
Negative working capital
 
$
(606,878
)

Management believes that the actions presently being taken and the success of future operations will be sufficient to enable the Company to continue as a going concern.

However, there can be no assurance that the raising of equity will be successful. Failure to achieve the needed equity funding could have a material adverse effect on the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
 
Off-Balance Sheet Arrangements
 
At June 30, 2013 and June 30, 2012, we had no material off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

ITEM 7A: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a Smaller Reporting Company, as defined by Rule 12b-2 of the Exchange Act and in Item 10 (f) (1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information  requested by this Item.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INDEX TO FINANCIAL STATEMENTS
Healthient, Inc. 
 
Report of  Independent Registered Public Accounting Firm
 F-1
Consolidated Balance Sheets as at June 30, 2013 and June 30, 2012
F-2
Consolidated  Statement of Operations for the year ended June 30, 2013, June 30, 2012
  F-3
Consolidated  Statements of Cash Flows for the year ended June 30, 2013, June 30, 2012
 F-5
Notes to Consolidated Financial Statements  for the years ended June 30, 2013 and 2012
 F-6
 
 
21
 
 

 

RONALD R. CHADWICK, P.C.

Certified Public Accountant

2851 South Parker Road, Suite 720

Aurora, Colorado  80014

Telephone (303)306-1967

Fax (303)306-1944

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Board of Directors

Healthient, Inc.

Jupiter, Florida

 

I have audited the accompanying consolidated balance sheets of Healthient, Inc.(a development stage company) as of June 30, 2013 and 2012, and the related consolidated statements of operations, stockholders' equity and cash flows for the years then ended. These financial statements are the responsibility of the Company's management. My responsibility is to express an opinion on these financial statements based on my audit.

 

I conducted my audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that I plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.  I believe that my audit provides a reasonable basis for my opinion.

 

In my opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Healthient, Inc. as of June 30, 2013 and 2012, and the consolidated results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements the Company has suffered recurring losses from operations and has a working capital deficit that raise substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Aurora, Colorado /s/ Ronald R. Chadwick, P.C.
September 26, 2013 RONALD R. CHADWICK, P.C.

 

F-1
 

Healthient, Inc.

Consolidated Balance Sheets

 

    June   June
    30, 2013   30, 2012
                 
ASSETS                
Current Assets                
Cash   $ 1,815     $ —    
Inventory     50,964       135,485  
Deposits and prepaid expenses     11,226       11,226  
Total Current Assets     64,005       146,711  
Property and Equipment                
Website costs (net of accummulated amortization)     37,576       97,908  
Licensed drink (net of accummulated amortization)     3,750       6,250  
Office equipment (net of depreciation)     13,723       16,378  
Total Fixed Assets     55,049       120,536  
Total Assets   $ 119,054     $ 267,247  
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)                
Current Liabilities                
Bank overdraft   $ —       $ 12,333  
Accounts payable     105,019       167,438  
Payroll taxes     3,565       3,280  
Sales tax liability     39       1,500  
Directors' fees     180,000       90,000  
Shareholder loans     382,260       210,254  
Total Current Liabilities     670,883       484,805  
Long Term Liabilities                
Settlement payable     —         1,719,000  
Total Liabilities     670,883       2,203,805  
Stockholders' Equity (Deficit)                
Preferred stock, $0.001 Par value, 25,000,000 authorized:                
No shares issued     —         —    
Common stock, $0.001 par value: 200,000,000 shares authorized, 17,460,678 and 2,289,721 shares issued and outstanding at June 30, 2013 and June 30, 2012, respectively     17,460       2,290  
Additional paid-in capital     17,515,613       9,508,249  
Deficit accumulated     (11,447,097 )     (11,447,097 )
Net loss current year     (6,637,805 )     —    
Total Stockholders' Equity     (551,829 )     (1,936,558 )
Total Liabilities and Stockholder's Equity   $ 119,054     $ 267,247  

The accompanying notes are an intergral part of these financial statements.

 

 
F-2
 

Healthient, Inc.

Statement of Operations

         
    For the year   For the year
    ended June   ended June
    30, 2013   30, 2012
Revenues   $ 161,954     $ 314,980  
Cost of revenues     105,672       181,158  
Gross profit     56,282       133,822  
Selling expenses     19,952       76,732  
General and administrative expenses     874,635       6,336,254  
Total     894,587       6,412,986  
Operating loss     (838,305 )     (6,279,164 )
Other income (expense)                
Settlement loss     (5,799,500 )     (1,719,000 )
Provision for income taxes     —         —    
Net loss   $ (6,637,805 )   $ (7,998,164 )
Net loss per share-Basic and                
Diluted   $ (1.22 )   $ (6.24 )
Weighted average number of Common shares outstanding, basic and fully diluted     5,419,916       1,282,394  

See accompanying notes to Financial Statements.

 

F-3
 

 

Healthient, Inc.

Consolidated Statements of Cash Flows

 

         
    For the Year   For the Year
    ended June   ended June
    30, 2013   30, 2012
Cash Flows from Operating Activities                
Net loss   $ (6,637,805 )   $ (7,998,164 )
Depreciation     3,250       3,388  
Amortization of Websites and license     62,832       59,118  
Shares issued for services     447,809       5,448,408  
Shares issued for settlement     5,843,500       —    
Changes in operating assets and liabilities                
Decrease (Increase) in inventory     84,521       (107,273 )
Increase in Directors' fees     90,000       90,000  
Increase in deposits and prepaid expenses     —         2,869  
Settlement payable     —         1,719,000  
Decrease in advanced sales tax     (1,461 )     1,500  
Increase (decrease) in accrued payroll taxes     285       (1,162 )
Increase (decrease) in account payable     (50,193 )     50,420  
Net Cash Used in Operations     (157,262 )     (731,896 )
Cash Flows from Investing Activities                
Furniture and office equipment     (595 )     (1,733 )
Net Cash Used in Investing Activities     (595 )     (1,733 )
Cash Flows from Financing Activities                
Officers loans advanced     172,005       201,343  
Bank overdraft     —         12,333  
Shares issued for cash             409,239  
Net Cash Provided by Financing Activities     172,005       622,915  
Net (decrease) increase in Cash     14,148       (110,714 )
Cash--Beginning of Period     (12,333 )     110,714  
Cash - Ending of Period   $ 1,815     $ —    
Supplemental Disclosure of Non-Cash Investing and Financing Activities:                
Shares issued for services   $ 447,809     $ 5,448,408  
Shares issued for officer and other loans and accounts payable   $ 12,225     $ 183,268  
Shares issued for settlement of law suit   $ 7,562,500     $ —    
Shares issued for services Directors' fees payable   $ —       $ 90,000  
Shares issued for license to produce drink   $ —       $ 7,500  
Income taxes paid   $ —       $ —    
Interest paid   $ —       $ —    

The accompanying notes are an integral part of these financial statements

 

F-4
 

 

Healthient, Inc.

Consolidated Statement of Stockholders' Equity (Deficit)

 

    Common Shares            
    Shares   Par Value
$0.001 		  Additional
Paid-In
Capital 		  Deficit
accumulated 		  Accumulated
Equity
(Deficit)
Balance June 30, 2011     1,048,524     $ 1,049     $ 3,341,075     $ (3,448,933 )   $ (106,809 )
Common stock cancelled 11/11/11 originally issued April 30, 2009     (156,120 )     (156 )     156               —    
Common stock issued for cash     76,802       77       409,162               409,239  
Common stock issued for subsciption payable     1,200       1       29,999               30,000  
Common stock issued for debt     73,307       73       183,195               183,268  
Common stock issued for services     1,225,008       1,225       5,447,183               5,448,408  
Common stock ussed for license     1,000       1       7,499               7,500  
Common stock issued for Directors' fees     20,000       20       89,980               90,000  
Net loss                             (7,998,164 )     (7,998,164 )
Balance June 30, 2012     2,289,721       2,290       9,508,249       (11,447,097 )     (1,936,558 )
Common stock cancelled (for services)     (9,843 )     (10 )     (54,126 )             (54,136 )
Common stock issued for services     389,200       389       166,331               166,720  
Shares issued for Settlement     14,384,000       14,384       7,548,116               7,562,500  
Share issued for convertible note     407,500       407       347,043               347,450  
Fractional shares - stock split     100                               —    
Net loss                             (6,637,805 )     (6,637,805 )
Balance June 30, 2013     17,460,678       17,460       17,515,613       (18,084,902 )   $ (551,829 )

The Company did a reverse split of stock of 50 for 1 on October 1, 2012 that has been retroactively reflected at June 30, 2013.

 

F-5
 

 

Healthient, Inc.

 

FOOTNOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years ended June 30, 2013 and 2012

 

 

Note 1. Reorganization and Line of Business

 

On October 5, 2010 Time Associates, a Nevada corporation (" the Company") acquired all of the issued and outstanding common stock of Healthient, Inc., a Nevada corporation organized April 29, 2009 ("Healthient") in exchange for the issuance by the Company of a total of 43,618,356 newly issued restricted shares of common voting stock to the Healthient shareholders pursuant the Agreement and Plan of Reorganization dated as of September 23, 2010. Prior to the issuance of the shares, the Company had 160,078 shares of common stock issued and outstanding. Subsequent to the exchange there were 43,778,434 shares issued and outstanding. The shareholders of Healthient owned 99.6% of the common stock outstanding of the Company after the issuance of the 43,618,356 shares. On November 15, 2010 Time Associates, Inc. name was changed to Healthient, Inc.

 

The acquisition of Healthient by the Company on October 5, 2010 has been accounted for as a purchase and treated as a reverse acquisition and re-capitalization since the former owners of Healthient controlled 99.6% of the total shares of Common Stock of the Company outstanding immediately following the acquisition. In November 2010 Healthient, Inc. changed its name to SnackHealthy, Inc.

 

On this basis, the historical financial statements prior to October 5, 2010 have been restated to be those of the accounting acquirer Healthient (now SnackHealthy, Inc.). The historical stockholders' equity prior to the reverse acquisition has been retroactively restated (a re-capitalization) for the equivalent number of shares received in the acquisition after giving effect to any difference in par value of the issuer's and acquirer's stock. The original 160,078 shares of common stock outstanding prior to the exchange reorganization have been reflected as an addition in the stockholders' equity account of the Company on October 5, 2010.

 

Healthient, Inc., and its wholly owned subsidiary, SnackHealthy, Inc., develop and market snacks and beverages with the objective of making healthy eating a fun experience for the entire family. The Company’s goal is to develop a portfolio of products and successfully position them as convenient, healthy solutions across several snacking occasions daily. The Company sold snacks through a network marketing distribution model until the third quarter of the year ended June 30, 2013 when it started marketing direct to retail stores and markets.  

 

The Company was in the Development Stage as defined in Accounting Standards Codified (ASC) No. 915, “Accounting and Reporting by Development Stage Enterprises” through June 30, 2011.  The Company had devoted substantially all of its efforts to the corporate formation. Activities during the Development Stage include developing the business plan and raising capital. The Company is now in operations.

 

F-6
 

 

Note 2  Significant Accounting Policies

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary SnackHealthy, Inc. All significant inter–company transactions and balances have been eliminated in consolidation.

 

Cash and cash equivalents

 

The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents.

 

Financial Instruments

 

The carrying value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and due to related parties, as reported in the accompanying balance sheets, approximates fair value.

 

Long-Lived Assets

 

In accordance with ASC 350, the Company regularly reviews the carrying value of intangible and other long-lived assets for the existence of facts or circumstances, both internally and externally, that may suggest impairment. If impairment testing indicates a lack of recoverability, an impairment loss is recognized by the Company if the carrying amount of a long-lived asset exceeds its fair value.

 

Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

 

Revenue Recognition

 

Revenue is recognized when products are shipped, which is when title and risk of loss pass to brand partners and preferred customers who are the Company’s customers. The Company requires credit card payment at the point of sale. The Company has determined that no allowance for doubtful accounts is necessary. Amounts received prior to shipment and title passage to brand partners are recorded as deferred revenue. The compensation plan for the Company’s brand partners generally does not provide rebates or selling discounts to brand partners who purchase its products and services. The Company classifies selling discounts and rebates, if any, as a reduction of revenue.

 

Inventory

 

Inventory comprises packaged healthy snacks ready for final sale, and is stated at the lower of cost or market value. Cost is determined by the first-in, first out method.

 

 
F-7
 

 

Property and Equipment

 

Property and equipment are stated at cost and depreciated on the straight line method over the estimated life of the asset, which is 3-7 years.

 

Websites Development Cost and License to produce drink

 

The Company has adopted the provisions of FASB Accounting Standards Codification No. 350 Intangible-Goodwill and Other. Costs incurred in the planning state of a websites are expensed, while costs incurred in the development stage are capitalized and amortized over the estimated three year life of the asset. The drink license is also being amortized over three years.

 

Income Taxes

 

The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”) Income Taxes.  Under ASC 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

Going Concern

 

The financial statements have been prepared assuming that the Company will continue as a going concern. The Company had a net loss of $6,637,805 during the year ended June 30, 2013. Cash used in operations for the year approximated $157,000. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital and implement its business plan.

 

Management believes that the actions presently being taken and the success of future operations will be sufficient to enable the Company to continue as a going concern.

 

However, there can be no assurance that the raising of equity will be successful. Failure to achieve the needed equity funding could have a material adverse effect on the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Stock-Based Compensation

 

In December 2004, the FASB issued FASB Accounting Standards Codification No. 718, Compensation – Stock Compensation .  Under FASB Accounting Standards Codification No. 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans.  As such, compensation cost is measured on the date of grant at their fair value.  Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.  The Company applies this statement prospectively.

 

 
F-8
 

 

Equity instruments (“instruments”) issued to other than employees are recorded on the basis of the fair value of the instruments, as required by FASB Accounting Standards Codification No. 718.  FASB Accounting Standards Codification No. 505, Equity Based Payments to Non-Employees defines the measurement date and recognition period for such instruments.  In general, the measurement date is when either a (a) performance commitment, as defined, is reached or (b) the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification.

 

Basic and Diluted Net Loss per Common Share

 

Net Loss per Common Share is computed pursuant to FASB Accounting Standards Codification No. 260, Earnings per Share .  Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed in the same way as for Basic net loss.

 

There are no warrants outstanding as of June 30, 2013.

 

Recent Accounting Pronouncements

 

There have been no recent accounting pronouncements of changes in accounting pronouncements that impacted the year ended June 30, 2013 and June 30, 2012, or which are expected to impact future periods, that were not already adopted and disclosed in prior periods.

 

Note 3.  Property and Equipment

 

The Company started the construction of several Websites, all of which have been completed and are being amortized over three years.

 

Property and equipment was as follows:

 

    June 30,   June 30,
    2013   2012
Website   $ 181,008     $ 181,008  
Amortization     143,432       83,100  
    $ 37,576     $ 97,908  
License for drink (amortized over three years   $ 7,500     $ 7,500  
      3,750       1,250  
    $ 3,750     $ 6,250  
Computers and furniture (depreciated three to seven years   $ 22,165     $ 21,750  
Depreciation     8,442       5,192  
    $ 13,723     $ 16,378  

The Company leases its office space. The current facility lease runs from July 1, 2011 through June 30, 2016. Our current lease payments are $4,642 per month including operating expense and tax. The lease increases three percent each of the following years. We maintain our executive and administrative offices in this facility. Our rental payments in fiscal 2012 were $75,917. Our rental payments for the year ended June 30, 2013 were $54,383. Future minimum payments under the office lease are approximately as follows: Year ended June 2014 $54,000; 2015 $55,000; and 2016 $56,000 for a total of $165,000.

 

 
F-9
 

 

 

Note 4 . Stockholders’ Deficit

 

The Company has authorized 200,000,000 shares of common stock with a par value of $.001 and 25,000,000 shares of preferred stock with a par value of $.001. The Company effected a 3 for 1 share exchange as part of its reverse acquisition in October 2010. All share amounts in the financial statements and footnotes reflect this action.

 

The Company authorized the issuance of 816,480 shares of common stock to the founders at the fair value of $13,480.  The fair value of the shares of $13,480 was recorded as an expense.

 

During the year ended June 30, 2010, the Company sold to investors 40,607 Units for cash of $672,500 with each unit containing one share of common stock and one common stock purchase warrant. 33,900 Units were sold at $17 per Unit with warrants exercisable at $17 per share. 5,850 Units were sold at $17 per Unit with warrants exercisable at $21 per share and 857 Units were sold at $12 per Unit with warrants exercisable at $21 per share.

 

During the year ended June 30, 2011 the Company sold investors 46,426 Units for cash of $594,485.  The Company issued 111,134 shares for services for $1,555,357 ($14 per share) and 30,685 under the 2010 Equity Compensation Plan for $506,302 ($17 per share).

 

During the year ended June 30, 2012 the Company issued 76,802 common shares for cash of $409,239 common shares in satisfaction of a stock subscription payable, 73,307 common shares for officer debt of $183,268; 1,225,008 common shares for services of $5,448,408; 20,000 common shares for director’s fees payable $90,000; and 1,000 common shares for a drink license $7,500.

 

On October 1, 2012 the Company effected a 50 to 1 reverse split of their common stock that has been reflected in the Stockholders’ Deficit.

 

During the year ended June 30, 2013 the Company issued 389,200 common shares for services of $166,200; cancelled 9,843 common shares that had been previously issued for services in the amount of $54,136; issued 14,384,000 shares in settlement of a lawsuit ($7,562,500) with $1,719,000 paying off a settlement payable and $5,843,000 recorded as additional expense, netted to $5,799,000 by forgiven amounts of $44,000; 407,500 shares in payment of a note payable $347,450, with $12,225 paying off the note and $335,225 recorded as extra expense. The Company used market price as fair market value.

 

On October 1, 2012 the Company effected a 50 to 1 reverse split of their common stock that has been reflected in the Stockholders’ Deficit.

 

 

Non-Employee Stock Options and Warrants

 

The Company accounts for non-employee stock options and warrants under ASC 718, whereby option and warrant costs are recorded based on the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. Unless otherwise provided for, the Company covers option and warrant exercises by issuing new shares.

 

At June 30, 2013 there were no warrants outstanding. All warrants issued in prior periods expired without being exercised.

 

Note 5. Shareholder Loans

 

Shareholder loans of $382,260 at June 30, 2013 are non interest bearing and due on demand, as were the loans of $210,254 outstanding at June 30, 2012.

 

 

 
F-10
 

 

Note 6.  Income Taxes

 

The components of the deferred tax asset are as follows:

 

    June 30, 2013     June 30, 2011  
             
Deferred tax assets            
Net operating loss carry-forward   $ 3,263,000     $ 1,900,000  
Valuation allowance     (3,263,000 )     (1,900,000 )
                 
Net deferred tax assets   $ -     $ -  

 

The Company had available approximately $16,319,000 at June 30, 2013 and $9,682,000 at June 30, 2012 of unused Federal and Florida net operating loss carry-forwards that may be applied against future taxable income. These net operating loss carry-forwards expire through 2033. There is no assurance that the Company will realize the benefit of the net operating loss carry-forwards.

 

ASC No. 740 requires a valuation allowance to be recorded when it is more likely than not that some or all of the deferred tax assets will not be realized.

 

Reconciliation of the differences between the statutory tax rate and the effective income tax rate is as follows at June 30, 2013 and June 30, 2012 respectively:

 

St Statutory rate 35%
St State taxes, net of Federal tax benefit 6%
   
N Net operating loss carry-forward 41%
E Federal effective tax rate 0%

 

Note 7. Other Matters

  In 2011 Siesta Flow LLC filed a legal action against the Company in the Twelfth Circuit Court of Sarasota County, Florida, alleging breach of contract and seeking damages in the amount of 92,000 plus costs. In April, 2012, the court has issued final summary judgment against the Company in the total amount of $95,500.  On April 27, 2012, the court issued an order to approve a settlement of the judgment issued against the Company.  According to the terms of the approved settlement, a third party and a non-party to the legal action against the Company, agreed to purchase the claim of Siesta Flow LLC. in the amount of $75,000 and additional claims against the Company from other parties, for a total amount of $95,500 in exchange for the issuance of 19,100,000 shares of common stock by the Company, subject to certain limitations on the issuance of such shares set forth in settlement. The Company has recorded the settlement agreement at the market price of the stock on the date of issuance.

 

During the year ended June 30, 2013 the Company issued 14,384,000 shares of common stock in payment ($7,562,500). At June 30, 2013 the Company had 4,716,000 common shares remaining to be issued in satisfaction of the settlement.

 

 

Note 8. Related Party Transactions  

 

During the year ended June 30, 2012 the Company issued 180,000 shares of common stock valued at $1,260,000, 659,764 shares of common stock valued at $1,649,410 and issued 10,000 shares of common stock  to pay 2011 Directors fees of $45,000 to the Chairman of the Board plus $30,000 in fair value. A Director of the Company converted loans made to the company totaling $183,268 to 73,307 shares of the Company’s common stock during the year.

 

During the year ended June 30, 2013 the Company accrued $90,000 for the fees of two Directors.

 

Directors of the Company had loan balances due of $382,260 and $210,254 at fiscal year end June 30, 2013 and 2012 from loaned to the Company for working capital advances.  The loan is non interest bearing and due upon demand.  

 

Included in accounts payable at June 30, 2013 is approximately $7,700 owed to an officer for compensation.

 

Note 9. Subsequent Events

 

As of September, 2013 a Director of the Company converted a portion of a loan made to the Company totaling $120,000 to a total of 24,000,000 shares of common stock, out of which 1,333,333 common shares were accounted as a conversion of the loan at a price of $0.09 per share and the remaining 22,666,667 shares of common stock valued at $2,040,000 was recorded as income to the Director in connection with the conversion of the loan.

 

 
F-11
 

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
 
None. 
 
ITEM 9A.  CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

The Company has disclosure controls and procedures (as defined in Rules 13a-14 and 15d-14 under the Securities Exchange Act of 1934, as amended) to ensure that material information contained in its filings with the Securities and Exchange Commission is recorded, processed, summarized and reported on a timely and accurate basis. Based on such evaluation, the Company's principal executive officer and principal financial officer have concluded that the Company's disclosure controls and procedures are effective at ensuring that material information is recorded, processed, summarized and reported on a timely and accurate basis in the Company's filings with the Securities and Exchange Commission. Since such evaluation there have not been any significant changes in the Company's internal controls, or in other factors that could significantly affect these controls.

Management’s Annual Report on Internal Control over Financial Reporting
 
Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.  Under the supervision and with the participation of our management, which consists of our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of the effectiveness of internal control over financial reporting based on criteria established in the framework in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), as supplemented by the COSO publication Internal Control over Financial Reporting – Guidance for Smaller Public Companies .  Based on their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our internal control over financial reporting was effective as of June 30, 2013, based on these criteria.
 
Changes in Internal Control over Financial Reporting
 
During the quarter ended June 30, 2013, there were no changes in our internal controls that have materially affected or are reasonably likely to have materially affected our internal control over financial reporting.
 
Our management, including the Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system is met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the company have been detected.
 

As of October 1, 2013, the Company had a miscommunication with its principal accountant regarding the inclusion of an original Report of Independent Registered Public Accounting Firm signed by the auditor in the Form 10-K filed on September 30, 2013.  The Company included the report in the filing under the belief that the report had been provided to the Company by the auditor.  The report was included in the Form 10-K as a result of a miscommunication with the auditor and made with no intent of providing an opinion that was not signed or otherwise not provided to the Company.  As of October 1, 2013, the Company has filed an amendment to the Form 10-K for the period ending June 30, 2013 including an original copy of the signed report provided by the auditor.  There were no changes to the financial statements or footnotes in the amended filing.

Based on the Company's detection of the above described failure in communication between the management and its auditors at the time of filing of the Company's financial report, the Company's management is going to conduct a full evaluation of the effectiveness of its internal control and procedures with respect to the above issue and implement such remediation initiatives as may be necessary to prevent it in the future.

 

 
22
 
 
ITEM 9B.  OTHER INFORMATION

On September 12, 2013, the Company's Board of Directors and its Majority Shareholders approved an amendment to its 2010 Equity Compensation Plan (the "Plan") providing for the issuance of an additional two million (2,000,000) shares of common stock and ratifying previous amendments of the Plan.  The action was approved by the written consent of 24,892,164 shares (60.04%).

 
PART III
 
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

The present directors and executive officers of the Company, their ages, positions held in the Company and duration of service are as follows:

Name
Age
Position
Since
Katherine West
43
Chief Executive Officer,
10/5/2010
   
President and Director
 
William Alverson
48
Director
10/5/2010
William Lindberg
81
Chief Financial Officer
10/5/2010
 
The term of office of each director and executive officer ends at, or immediately after, the next annual meeting of shareholders of the Company. Except as otherwise indicated, no organization by which any director of officer has been previously employed is an affiliate, parent, or subsidiary of the Company.

Business Experience

The following is a brief account of the business experience during at least the past five years of each director and executive officer, including the principal occupation and employment during that period, and the name and principal business of the organization in which such occupation and employment were carried out.

Katherine West – Director, President and Chief Executive Officer of Healthient, Inc. and SnackHealthy, Inc.
 
As Chief Executive Officer, Ms. West oversees the management team and entire day-to-day operations of Healthient, Inc. and its subsidiary, SnackHealthy, Inc. She has extensive knowledge in direct sales, executive management and public company experience having served for Travelstar on the Board of Directors and having held the titles of Executive Vice President and Chief Financial Officer. 

From 1998 to 2002, Ms. West served as the COO of WMA & Associates. WMA provided early stage financing and led the public offerings of Baby Genius and FreeRealTime.com. She held various roles at Travelstar, Inc. including Executive Vice President, Chief Financial Officer and also served on the Board of Directors. The Company went public in 2004.  As Executive Vice President, she managed the day-to-day operations including 36 employees and over 500 travel agents. The Company grew from a start-up to $80,000,000 in annual sales in just 4 years. In late 2008, the Company was forced to close its doors after losing its contract with its major supplier and could not recover in the world economic crisis and financial market meltdown of that period. In connection with her tenure as a director and executive officer, Ms. West was named in the involuntary bankruptcy proceeding filed in 2008. In September, 2011, the trustee filed for the dismissal of the case against Ms. West.  Ms. West lives in Jupiter, Florida with her husband Bill and their four children.  In addition to running the Company and taking care of her family, Kathy enjoys playing tennis and is the captain of her tennis team.
 
 
23
 
 
William M. Alverson – Director

William Alverson serves as the Director of the Company (in his capacity as the Chairman of the Board of Directors) and senior executive of Healthient and SnackHealthy. He started his career in the financial industry in 1989 where he worked as a financial advisor at American Express. In 1993, Mr. Alverson founded Newport Beach, California based investment bank, WMA & Associates. Mr. Alverson served as Chairman and CEO providing first round financings and advisory services to both private and public companies. Major investments included Travelmax, Inc., Admore Memory, Freerealtime.com, Genius Products and Travelstar.  In 1995, as the largest investor and shareholder of Travelmax, he assumed the role of CEO. Under Mr. Alverson’s watch, the company grew from seven employees to 220 employees in less than one year, supporting over 44,000 agents nationwide. In 1997, Mr. Alverson was involved in an off-road racing accident in Mexico that left him temporarily paralyzed with a broken back. As a result of the injury and one-year rehabilitation, Mr. Alverson stepped down as CEO moving away from the day-to-day management of the company and sold off the majority interest in his holdings. In 1998, he returned to work resuming his role as CEO of WMA & Associates. Over the next several years, Mr. Alverson, and his team of investment bankers began investing in start-ups. WMA provided early stage financing and led the public offerings of Baby Genius and FreeRealTime.com.  In 2004, Mr. Alverson led Travelstar, Inc.’s growth from start up to $80,000,000 in annual sales in 4 years.  In late 2008, the Company was forced to close its doors after losing its contract with its major supplier and could not recover in the world economic crisis and financial market meltdown of that period. In connection with his tenure as a director and executive officer, Mr. Alverson was named in the involuntary bankruptcy proceeding filed in 2008. In September, 2011, the trustee filed for the dismissal of the case against Mr. Alverson.  Mr. Alverson lives in Jupiter, Florida. He is married and has four children with his wife of 15 years, Kathy.  He currently serves on the boards of Jupiter Ventures, Healthient, Inc., SnackHealthy, Inc. and The Healthient Foundation.

William Lindberg - Chief Financial Officer

Mr. Lindberg is responsible for the Company's finance functions, including tax, financial planning, treasury, accounting, capital allocation, procurement, internal audit, and investor relations. His prior experience includes serving in executive financial positions at both public and private companies. Early in his career, Mr. Lindberg was a Certified Public Accountant at Arthur Anderson & Co. assigned to its offices in Montevideo, Buenos Aires, and Santiago.

LIMITATION ON DIRECTORS' LIABILITIES

Our certificate of incorporation limits, to the maximum extent permitted under Nevada law, the personal liability of directors and officers for monetary damages for breach of their fiduciary duties as directors and officers, except in circumstances involving wrongful acts, such as a breach of the director's duty of loyalty or acts of omission which involve intentional misconduct or a knowing violation of law.

Nevada Law permits us to indemnify officers, directors or employees against expenses, including attorney's fees, judgments, fines and amounts paid in settlement in connection with legal proceedings if the officer, director or employee acted in good faith and in a manner he reasonably believed to be in or not opposed to our best interest, and, with respect to any criminal act or proceeding, he had no reasonable cause to believe his conduct was unlawful. Indemnification is not permitted as to any matter as to which the person is adjudged to be liable unless, and only to the extent that, the court in which such action or suit was brought upon application that, despite the adjudication of liability, but in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper. Individuals who successfully defend this type of action are entitled to indemnification against expenses reasonably incurred in connection therewith.

Our by-laws require us to indemnify directors and officers against, to the fullest extent permitted by law, liabilities which they may incur under the circumstances described in the preceding paragraph.
 
 
24
 
 
The Company is not subject to the requirements of Section 16(a) of the Securities Exchange Act of 1934, as amended.

CODE OF BUSINESS CONDUCT AND ETHICS

Our code of business conduct and ethics, as approved by our board of directors, can be obtained from the Company by writing a request to our Healthient, Inc. corporate office.

We intend to satisfy the disclosure requirement under Item 10 of Form 8-K relating to amendments to or waivers from provisions of the code that relate to one or more of the items set forth in Item 406(b) of Regulation S-B, by describing on our Internet Website, within five business days following the date of a waiver or a substantive amendment, the date of the waiver or amendment, the nature of the amendment or waiver, and the name of the person to whom the waiver was granted.

Information on our Internet website is not, and shall not be deemed to be, a part of this report or incorporated into any other filings we make with the Securities and Exchange Commission.
 
ITEM 11. EXECUTIVE COMPENSATION

The following table sets forth information concerning the annual and long-term compensation for services rendered during the last three fiscal years to our company in all capacities as an employee by our Chief Executive Officer and our other executive officers whose aggregate cash compensation exceeded $100,000 (collectively, the "named executive officers") at any time during such years.

Summary Compensation Table for 2013 and 2012 Fiscal Years
 
Name and Principal Position
 
Year
 
Salary
($)
 
Bonus
($)
 
Stock Awards
($)(1)(3)
 
Option Awards
($)
 
All Other
Compensation ($(2))
 
Total
($)
 
Katherine West
President and CEO (1)
 
2013
   
_
   
_
   
_
   
_
   
_
 
_
 
   
2012
   
-
   
_
   
-
   
_
   
_
 
-
 
William Alverson
Chairman of the Board of Directors (2)(3)
 
2013
   
9
   
_
   
-
   
_
   
10
 
9
 
   
2012
   
7,359
   
_
   
1,260,000
   
_
   
1,649,410
 
2,916,769
 
William Lindberg
Chief Financial Officer
 
2013
   
6,000
   
_
   
10,300
   
_
   
_
 
 
16,300
 
   
2012
   
8,123
   
_
   
7,090_
   
_
   
_
 
15,213
 
_________________________ 
   
(1)  
Mr. Alverson has been issued 9,000,000 shares of common stock of the Company at the price per share of $0.08 per share pursuant to the Company's Equity Compensation Plan of 2010 as amended.

(2)  
Mr. Alverson has been issued 32,988,211 shares of common stock of the Company for the conversion of a loan made to the Company.  See "Related Party Transactions".
(3)  
Mr. Lindberg has been issued 70,000 shares of common stock of the Company at the price per share of $0.10 per share pursuant to the Company’s Equity Compensation Plan of 2010, as amended.
 
 
25
 
 
Outstanding Equity Awards
 
The table below shows all outstanding equity awards held by our Named Executive Officers at the end of the fiscal year ended June 30, 2013.
  
Outstanding Equity Awards at 2013 Fiscal Year End
 
   
Option Awards
Name
 
Number of Securities Underlying Unexercised Options Exercisable
(#)
 
Number of Securities Underlying Unexercised Options Unexercisable
(#)
 
Grant Date
 
Option Exercise Price ($)
 
Option Expiration Date
Katherine West
 
_
   
_
   
_
 
_
 
_
 
William Alverson
 
_
   
_
   
_
 
_
 
_
 
William Lindberg
 
_
   
_
   
_
 
_
 
_
 
   
COMPENSATION OF DIRECTORS

The table below summarizes the compensation earned by directors for services during the fiscal year ended June 30, 2013. Please also see Item 13 Certain Relationships and Related Transactions and Note 8 to the Financial Statements.
 
Director Compensation
  
For Fiscal Year Ended June 30, 2013
 
Name
 
Fees
Earned
or Paid
in Cash
($)
 
Option
Awards
($)
   
All Other
Compensation
($)
 
Total
($)
 
                           
Katherine West
   
_
   
_
   
45,000 (1)
   
45,000
 
William Alverson
   
_
   
_
   
45,000 (1)
   
45,000
 
_____________________
(1)  
The company recorded a payable of $45,000 for shares of common stock to each Ms. West and Mr. Alverson for their respective services as directors valued at $45,000 pursuant to the Company's 2010 Equity Compensation Plan, as amended.  
 
 
26
 
 
The Company reimburses each Director for reasonable expenses (such as travel and out-of-pocket expenses) in attending meetings of the Board of Directors.

EMPLOYMENT AGREEMENTS, TERMINATION OF EMPLOYMENT AND CHANGE-IN-CONTROL ARRANGEMENTS

There are no employment agreements with the Company's key employees at this time.

EQUITY COMPENSATION PLAN INFORMATION

In fiscal year 2011, the Company adopted its 2010 Equity Compensation Plan (the "Plan") which was registered on the registration statement on Form S-8. The Company registered 8,500,000 shares of its common stock.  The Plan was amended in January 2012, and the Company registered an additional 12,000,000 shares of its common stock.  Pursuant to the Plan, the Company issued a total of 6,762,143 shares of its common stock to employees, as that term is defined under the Plan. As of June 30, 2013, there were no shares of common stock remaining for issuance under the Plan.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth certain information with respect to beneficial ownership of our common stock by: (i) each person known by us to be the beneficial owner of more than 5% of our common stock; (ii) each of our current directors; (iii) each of our executive officers set forth in the Summary Compensation Table; and (iv) all current directors and executive officers as a group. Except as otherwise indicated, the address for each person is 15132 Park of Commerce Blvd., Jupiter, FL 33478.  Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. Except as otherwise indicated in the footnotes to the table, and subject to community property laws, where applicable, the persons and entities identified in the table below have sole voting and investment power with respect to all shares beneficially owned. The number of shares of common stock outstanding used in calculating the percentage for each listed person includes shares of common stock underlying options or warrants held by such person that are exercisable within 60 calendar days of August 31, 2013 but excludes shares of common stock underlying options or warrants held by any other person.  Percentage of beneficial ownership is based on 41,460,678 shares of common stock issued and outstanding as of September 18, 2013.
 
 
Beneficial Ownership
 
Percentage
 
of Common Stock (1)
 
of Ownership
Katherine West
Director, CEO and President
152,114
 
 0.37%
       
William Alverson
Director
24,740,050 (2)
 
59.67%
       
William Lindberg
8,000
 
0.04%
Chief Financial Officer
     
 
All current executive officers and directors as a group (3 persons)
 
24,900,164
 
 
60.08%
 
*
Less than 1%
 
(1) Beneficial ownership is determined in accordance with rules and regulations of the Securities and Exchange Commission. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of common stock subject to options or warrants held by that person that are currently exercisable or exercisable within 60 days after August 31, 2013 are deemed outstanding, but are not deemed outstanding for computing the percentage of any other person.
 
(2) Mr. Alverson holds 15,006,651 of his shares of common stock in Northeast Capital Group, LLC.; 9,639,072 of his shares of common stock in Panacea Holdings, Inc., and3,327 of his shares of common stock in MPB & Associates. Inc., the companies he owns and controls.
 
 
27
 
 
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
 
During the year ended June 30, 2013 the Company accrued $90,000 for the fees of two Directors.  See Executive Compensation.

Directors of the Company had loan balances of $382,260 and $210,254 at fiscal year June 30, 2013 and 2012, respectively, due to them from the Company. The proceeds of such loan from the directors to the Company were used for working capital advances.   The loan is non interest bearing and due upon demand.  See Notes 5 and 8 to the Financial Statements.  

Directors of the Company had loan balances due of $210,254 and $192,179 at fiscal year June 30, 2012 and 2011, respectively from the Company for working capital advances.   The loan is non interest bearing and due upon demand.  A director of the Company and senior executive of the Company's wholly-owned subsidiary of the Company converted the loan made to the Company totaling $183,268 to a total of 36,653,568 shares of common stock, out of which 3,665,357 shares of the Company’s common stock were accounted as a conversion of the loan at a price of $0.05 per share and the remaining 32,988,211 shares of common stock valued at $1,649,410 were recorded as income to Mr. Alverson in connection with the conversion of the loan.  

Other than disclosed in the Financial Statements, there were no transactions for the fiscal year ended June 30, 2013, nor are there any current proposed transactions, or series of the same, to which the Company is a party, in which the amount exceeds $60,000 and in which, to the knowledge of the Company, any director, executive officers, nominee, five percent shareholders of any member of the immediate family of the foregoing person, have or will have a direct or indirect material interest.

 
28
 
 
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The following table presents fees for professional audit services rendered by:

Ronald R. Chadwick, P.C.
Certified Public Accountant
2851 South Parker Road, Suite 720
Aurora, Colorado  80014
    
for the year ended June 30, 2013

   
2013
 
Audit Fees: (1)
 
$
11,500
 
Audit-Related Fees: (2)
   
4,500
 
Tax Fees: (3)
   
--
 
All Other Fees: (4)
   
--
 
Total
 
$
16,000
 

(1) Audit Fees: Fees for professional services performed by Ronald R. Chadwick, P.C. for the audit of our annual financial statements and services that are normally provided in connection with statutory and regulatory filings or engagement, such as the filing of Form S-8 for the year ended June 30, 2013

(2) Audit-Related Fees: Fees for the review of 10-Q’s for the first, second and third quarters for the year ended June 30, 2013.

(3) Tax Fees: Ronald R. Chadwick, P.C. did not provide any professional services with respect to tax compliance, such as preparation and filing of original and amended returns for us and our consolidated subsidiaries, refund claims, payment planning, tax audit assistance and tax work stemming from "Audit-Related" items.

(4) All Other Fees: Ronald R. Chadwick, P.C. did not provide other permissible work for us that does not meet the above category descriptions.
   
PRE-APPROVAL POLICY

Our Board of Directors is responsible for approving all Audit, Audit-Related, Tax and Other Non-Audit Services. The Board of Directors approves all auditing services and permitted non-audit services, including all fees and terms to be performed for us by our independent auditor at the beginning of the fiscal year.

Non-audit services are reviewed and pre-approved by project at the beginning of the fiscal year. Any additional non-audit services contemplated by the company after the beginning of the fiscal year are submitted to the Audit Committee chairman for pre-approval prior to engaging the independent auditor for such services. Such interim pre-approvals are reviewed with the full Audit Committee at its next meeting for ratification.

 
29
 
 
PART IV

ITEM 15.  EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
    
Exhibit No.
 
Description of Document
     
2.1
 
Agreement and Plan of Merger of Time Lending, California, Inc.*
     
3.1
 
Articles of Incorporation of Time Lending, California, Inc.*
     
3.2
 
Articles of Incorporation of Tenth Street, Inc.*
     
3.3
 
Articles of Incorporation of Time Marketing Associates, Inc.*
     
3.4
 
Articles of Incorporation of Time Management, Inc.*
     
3.5
 
Articles and Certificate of Merger of Registrant*
     
3.6
 
Bylaws of Registrant*
     
3.7
 
Amendment to the Articles of Incorporation dated August 2, 2005*
3.8 
 
Certificate of Designation.* 
3.9
 
Amendment to the Articles of Incorporation dated August, 2011.*
3.10
 
Amendment to the Articles of Incorporation dated September, 2012.*
10.2
 
Lease Agreement*
     
10.3
 
Guaranty of Michael Pope*
     
10.4
 
Guaranty of Thomas Van Wagoner*
     
10.5
 
Demand Promissory Note (Michael Pope)*
     
10.6
 
Demand Promissory Note (Philip La Puma)*
      
 
30
 
    
10.7
 
Asset Sale and Purchase Agreement*
     
10.8
 
Share Exchange Agreement between Time Financial Services, Inc. and Interruption Television, Inc.*
     
10.9
 
Voting Agreement (Tenth Street, Inc.)*
     
10.10
 
Voting Agreement (Time Management, Inc.)*
     
10.11
 
Voting Agreement (Time Marketing Associates, Inc.)*
     
10.12
 
Broker Agreement*
     
10.13
 
Letter of Intent with Nationwide Security Mortgage*
     
21
 
Subsidiaries of Registrant
     
31.1
 
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act
     
31.2
 
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
     
32.1
 
Certification of Chief Executive Officer pursuant to 18 U.S.C. Ss. 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2
 
Certification of Chief Financial Officer pursuant to 18 U.S.C. Ss. 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
________________________
* Previously filed with the Commission.
 
 
31
 
 
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: September  , 2013
HEALTHIENT, INC.
     
 
By:
/s/ Katherine West
   
Katherine West
   
President
     
 
By:
/s/  William Lindberg
   
William Lindberg
   
Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SIGNATURE
 
TITLE
 
DATE
         
/s/ Katherine West
 
President and Director
 
September 16, 2013
Katherine West
 
(PRINCIPAL EXECUTIVE OFFICER)
   
         
/s/  William Lindberg
William Lindberg
 
Chief Financial Officer (PRINCIPAL FINANCIAL OFFICER)
 
September 16, 2013
         
         
         
/s/ William Alverson
 
Director
 
September 16, 2013
William Alverson
       
 
 
32
 
Curative Biosciences (CE) (USOTC:CBDX)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Curative Biosciences (CE).
Curative Biosciences (CE) (USOTC:CBDX)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Curative Biosciences (CE).